A Study of Oprozomib, Melphalan, and Prednisone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma
Clinical trial NCT02072863 · COMPLETED
Trial details
- NCT number
- NCT02072863
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2015-01-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.